Skip to main content
. 2021 Feb 19;12(2):201. doi: 10.1038/s41419-021-03489-y

Fig. 1. Identification of an essential lncRNA CDKN2B-AS1 whose overexpression is associated with poor prognosis of KIRC.

Fig. 1

a Analysis of lncRNAs which were differentially expressed and related to KIRC survival in TCGA, using circlncRNAnet and OncoLnc database, respectively. b Venn diagram presenting the lncRNAs that were upregulated (1808 lncRNAs), related to survival (1558 lncRNAs), or both (14 lncRNAs) in KIRC. c The 14 lncRNAs which were upregulated and related to a shorter survival in KIRC. d qRT-PCR analysis of CDKN2B-AS1 expression in 42 paired KIRC tissues (tumor) and adjacent normal tissues (adjacent); β-actin was used as the internal control. eh CDKN2B-AS1 expression was analyzed in KIRC patients regarding tumor size (e), histologic grade (f), TNM stage (g), and metastasis status (h), using RNA-seq data in TCGA. Error bars represent the SEM. i, j Kaplan–Meier analysis showed the overall survival and disease-free survival in KIRC patients based on the expression of CDKN2B-AS1 in TCGA dataset, the high and low expression groups were divided by the median of CDKN2B-AS1 levels. P value calculated by paired-sample t test (d), independent sample t test (e, h), one-way ANOVA (f, g), or log-rank test (i, j).